Results 161 to 170 of about 1,367,754 (318)

Aquaporin‐3 and aquaporin‐5 impact the development of pancreatic ductal adenocarcinoma spheroids

FEBS Open Bio, EarlyView.
Schematic representation of the role of aquaporin‐3 (AQP3) and aquaporin‐5 (AQP5) in pancreatic ductal adenocarcinoma (PDAC). Both proteins are upregulated in PDAC and are associated with tumor progression and metastatic potential. Silencing AQP3 or AQP5 in PDAC spheroids results in decreased diameter, area, and overall growth, underscoring their key ...
Catarina Pimpão, Diogo M. Engrácia, Graça Soveral, Filipa Mendes   +3 more
wiley   +1 more source

Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis. [PDF]

PLoS One
Yang S, Hou Y, Wang X, Kang S, Pan Z.
europepmc   +1 more source

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

FEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis

, 2018
Pei Wu,1 Pengliang Wang,1 Bin Ma,2 Songcheng Yin,1 Yuen Tan,1 Wenbin Hou,1 Zhenning Wang,1 Huimian Xu,1 Zhi Zhu1 1Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang 110001, China; 2Department of Colorectal ...
Wang ZN, Ma B, Hou WB, Zhu Z, Xu HM, Wu P, Wang PL, Yin SC, Tan YE   +8 more
core  

Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer. [PDF]

J Immunother Cancer
Miyamoto T, Ye Y, Soliman MM, Manning BS, Murphy B, Zhu L, Shao C, Mirji G, Minakuchi M, Hamada K, Mizuno R, Taki M, Yamanoi K, Murakami R, Mandai M, Ye Y, Wickramasinghe J, Nefedova Y, Shinde R, Kossenkov A, Zhang N.   +20 more
europepmc   +1 more source

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha, Bishwas Mandal, Vishal Mandal, Asis Shrestha, Amir Babu Shrestha   +4 more
wiley   +1 more source

Neoadjuvant chemotherapy for pineal region tumors. [PDF]

J Neurooncol
Troy C, Laird DG, Brimley C, Pinto S, Himel S, Osorno-Cruz C, Motiwala M, Lesha E, Chamberlin K, Robinson G, Gajjar A, Chiang J, Shimony N, Hersh DS, Klimo P.   +14 more
europepmc   +1 more source

Re‐Awakening Public Attention to the Silent Pandemic of Cancer Among Older Adults in Low‐ and Middle‐Income Countries

Aging and Cancer, EarlyView.
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef, Sunkanmi Folorunsho, Abdulazeez Opeyemi Abdulganiyu   +2 more
wiley   +1 more source

Quality of life in patients receiving platinum based chemotherapy for advanced non-small cell lung cancer.

, 2006
Quality of life in patients receiving platinum based chemotherapy for advanced non-small cell lung cancer. Lung cancer is the cause of 34,000 deaths in the UK each year, with a five year survival rate of only 7.5%.
Leary, A.
core  

Serplulimab Plus Chemotherapy, with or without HLX04, versus Chemotherapy as First-Line Treatment for Nonsquamous NSCLC: Final Survival Analysis of the Phase III ASTRUM-002 Study. [PDF]

Cancer Commun (Lond)
Hao X, Wang L, Hao Y, Hu Y, Chen C, Chen B, Huang Y, Zang A, Wang Y, Chen Z, Zhuang W, Shi J, Ren X, Nie L, Yu G, Luo F, Mao Y, Wang X, Li B, Bai Y, Shi J, Ni H, Hou X, Yu H, Li J, Wang Q, Zhu J, Shi Y, ASTRUM-002 Study Group.   +28 more
europepmc   +1 more source